PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
+10.13%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$1.45B
AUM Growth
+$1.45B
(+29%)
Cap. Flow
+$181M
Cap. Flow
% of AUM
12.5%
Top 10 Holdings %
Top 10 Hldgs %
32.03%
Holding
256
New
67
Increased
49
Reduced
31
Closed
33
Top Buys
| 1 |
IMDX
Insight Molecular Diagnostics Inc. Common Stock
IMDX
|
$30.8M |
| 2 |
APR
Apria, Inc. Common Stock
APR
|
$21.4M |
| 3 |
Align Technology
ALGN
|
$19M |
| 4 |
Intellia Therapeutics
NTLA
|
$15.2M |
| 5 |
CUTR
Cutera, Inc.
CUTR
|
$15M |
Top Sells
| 1 |
Vericel Corp
VCEL
|
$17.6M |
| 2 |
AFIB
Acutus Medical, Inc. Common Stock
AFIB
|
$13.5M |
| 3 |
Sotera Health
SHC
|
$12.9M |
| 4 |
Option Care Health
OPCH
|
$12.1M |
| 5 |
Haemonetics
HAE
|
$9.8M |
Sector Composition
| 1 | Healthcare | 80.26% |
| 2 | Industrials | 3.49% |
| 3 | Materials | 1.12% |
| 4 | Financials | 1.09% |
| 5 | Consumer Staples | 0.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Establishment Labs
ESTA
$1.2B
| $68.8M | 1.96% | 1,100,834 -81,612 | -7% | -$5.1M |
|
|
NSTG
2
DELISTED
NanoString Technologies, Inc.
NSTG
| $66.3M | 1.89% | 1,009,027 -6,337 | -0.6% | -$416K |
|
|
IMDX
3
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| $63.4M | 1.81% | 12,223,953 +5,941,130 | +95% | +$30.8M |
|
|
INOV
4
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $47.4M | 1.35% | 1,648,358 +218,974 | +15% | +$6.3M |
|
5
Inspire Medical Systems
INSP
$2.77B
| $42.3M | 1.2% | 204,187 +13,645 | +7% | +$2.82M |
|
|
VRAY
6
DELISTED
ViewRay, Inc.
VRAY
| $41.9M | 1.19% | 9,632,701 +1,837,114 | +24% | +$7.99M |
|
7
AtriCure
ATRC
$1.84B
| $40.4M | 1.15% | 615,950 -99,699 | -14% | -$6.53M |
|
|
MDVL
8
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
| $31.6M | 0.9% | 2,342,213 -245,801 | -9% | -$3.32M |
|
9
ICU Medical
ICUI
$3.15B
| $30.5M | 0.87% | 148,548 -25,851 | -15% | -$5.31M |
|
10
STAAR Surgical
STAA
$1.36B
| $30.3M | 0.86% | 287,238 -70,818 | -20% | -$7.46M |
|
11
Organogenesis Holdings
ORGO
$653M
| $27.5M | 0.78% | 1,507,552 -300,002 | -17% | -$5.47M |
|
12
Hydrofarm Holdings
HYFM
$21.6M
| $27M | 0.77% | 448,324 +73,324 | +20% | +$4.42M |
|
13
Natera
NTRA
$23.1B
| $25.1M | 0.72% | 247,644 +45,144 | +22% | +$4.58M |
|
|
ALXN
14
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $23.9M | 0.68% | 156,581 +32,685 | +26% | +$5M |
|
|
RCM
15
DELISTED
R1 RCM Inc. Common Stock
RCM
| $23.4M | 0.67% | 946,487 +34,647 | +4% | +$855K |
|
|
APR
16
DELISTED
Apria, Inc. Common Stock
APR
| $21.4M | 0.61% | +766,712 | New | +$21.4M |
|
|
17
Vericel Corp
VCEL
$1.83B
| $20.8M | 0.59% | 374,435 -317,380 | -46% | -$17.6M |
|
18
Pulmonx
LUNG
$69.7M
| $20.3M | 0.58% | 442,896 +50,254 | +13% | +$2.3M |
|
19
Outset Medical
OM
$247M
| $19.8M | 0.56% | 364,267 -139,155 | -28% | -$7.57M |
|
20
Pacific Biosciences
PACB
$393M
| $19.6M | 0.56% | 586,955 -189,075 | -24% | -$6.3M |
|
|
XENT
21
DELISTED
Intersect ENT, Inc
XENT
| $19M | 0.54% | 909,660 +53,937 | +6% | +$1.13M |
|
|
22
Align Technology
ALGN
$10.3B
| $19M | 0.54% | +35,000 | New | +$19M |
|
23
LivaNova
LIVN
$3.08B
| $18.6M | 0.53% | 252,402 -6,401 | -2% | -$472K |
|
24
SI-BONE Inc
SIBN
$719M
| $17.5M | 0.5% | 550,104 -33,455 | -6% | -$1.06M |
|
|
AMRS
25
DELISTED
Amyris Inc.
AMRS
| $16.1M | 0.46% | 845,022 +495,022 | +141% | +$9.45M |
|